|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-5-19
|
|
pubmed:abstractText |
Mometasone furoate nasal spray (MFNS, NASONEX ), is a new synthetic corticosteroid with considerable efficacy in the treatment of seasonal and perennial rhinitis and less than 0.1% systemic absorption. This study was designed to evaluate the time of onset of action of MFNS. The subjects were evaluated over the course of 2 weeks during the spring allergy season.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0105-4538
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
64-9
|
|
pubmed:dateRevised |
2005-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10195359-Administration, Intranasal,
pubmed-meshheading:10195359-Adolescent,
pubmed-meshheading:10195359-Adult,
pubmed-meshheading:10195359-Anti-Allergic Agents,
pubmed-meshheading:10195359-Child,
pubmed-meshheading:10195359-Double-Blind Method,
pubmed-meshheading:10195359-Female,
pubmed-meshheading:10195359-Humans,
pubmed-meshheading:10195359-Male,
pubmed-meshheading:10195359-Middle Aged,
pubmed-meshheading:10195359-Pregnadienediols,
pubmed-meshheading:10195359-Rhinitis, Allergic, Seasonal,
pubmed-meshheading:10195359-Self Care,
pubmed-meshheading:10195359-Time Factors
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis.
|
|
pubmed:affiliation |
Atlanta Allergy and Immunology Research Foundation, GA, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
